Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.

Legend Star and CMB International are among the participants in the cancer drug developer’s latest round, which was led by Tsing Song Capital.

Tencent Investment was among the participants in late-stage round for the online medical information and social networking service.

The intelligent chipmaker, which counts Microsoft, Samsung, BMW, Robert Bosch and Dell as investors, secured series E funding at a $2.77bn valuation.

The Archermind-backed operating system developer was reportedly valued at $734m valuation in a $168m round led by Beijing E-Town.

Bojia Capital reinvested in the Tencent-backed online arts education provider in a round that pushed its overall funding to $305m.

Lilly Asia Ventures has put more funding into Transcenta to help sustain the antibody drug developer's clinical-stage pipeline.

The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.

The intelligent chipmaker, which traces its roots back to University of Bristol, has secured series E funding at a $2.77bn valuation.

Alibaba and SoftBank Vision Fund helped the online education services provider close a series E-plus round that hiked its overall funding to more than $2.9bn.